Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-02 Sale |
2023-08-04 5:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
65,015 | $13.04 | $847,712 | 10,297,052 (Indirect Direct) |
View |
| 2023-07-12 Sale |
2023-07-14 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
56,818 | $12.54 | $712,242 | 10,372,067 (Indirect Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 5:12 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
56,436 | $9.0511 | $510,808 | 10,438,885 (Indirect Direct) |
View |
| 2023-05-03 Sale |
2023-05-05 6:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
58,073 | $4.7928 | $278,335 | 30,174,484 (Indirect Direct) |
View |
| 2022-01-05 Sale(A) |
2023-04-28 4:32 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
18,500 | $7.3875 | $136,669 | 73,549,979 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-07 5:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
53,327 | $6.5953 | $351,710 | 10,584,055 (Indirect Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 5:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
110,890 | $8.0521 | $892,894 | 10,650,382 (Indirect Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:07 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $7.9175 | $166,268 | 10,771,272 (Indirect Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 5:11 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $9.2172 | $193,561 | 10,793,618 (Indirect Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 6:28 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $7.3872 | $155,131 | 9,584,550 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 6:17 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,710 | $9.0392 | $358,947 | 9,662,550 (Indirect Direct) |
View |
| 2022-11-03 Sale |
2022-11-04 6:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,193 | $10.01 | $392,200 | 9,708,011 (Indirect Direct) |
View |
| 2022-10-06 Sale |
2022-10-07 7:19 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,553 | $11.58 | $446,574 | 9,747,204 (Indirect Direct) |
View |
| 2022-09-01 Sale |
2022-09-02 7:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,066 | $10.35 | $404,199 | 9,785,757 (Indirect Direct) |
View |
| 2022-08-04 Sale |
2022-08-05 7:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,325 | $9.4865 | $373,058 | 9,843,210 (Indirect Direct) |
View |
| 2022-07-07 Sale |
2022-07-08 6:36 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,614 | $9.0535 | $358,647 | 9,882,535 (Indirect Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 8:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,190 | $6.1063 | $257,625 | 9,909,513 (Indirect Direct) |
View |
| 2022-05-04 Sale |
2022-05-06 8:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
55,330 | $6.4685 | $357,900 | 18,002,176 (Indirect Direct) |
View |
| 2022-04-28 Sale |
2022-05-02 9:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,675 | $6.1405 | $495,381 | 19,174,770 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 9:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
80,108 | $6.1701 | $494,275 | 26,290,299 (Indirect Direct) |
View |
| 2022-04-18 Sale |
2022-04-20 9:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,336 | $6.8302 | $261,842 | 10,185,580 (Indirect Direct) |
View |
| 2022-04-14 Sale |
2022-04-18 9:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
37,017 | $7.5541 | $279,630 | 10,223,916 (Indirect Direct) |
View |
| 2022-04-08 Sale |
2022-04-12 8:05 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,420 | $6.5954 | $259,991 | 10,260,933 (Indirect Direct) |
View |
| 2022-04-07 Sale |
2022-04-11 8:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,218 | $6.5409 | $256,520 | 10,300,353 (Indirect Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 7:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
38,326 | $6.7609 | $259,119 | 10,321,071 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-07 9:15 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
36,972 | $7.425 | $274,518 | 10,359,397 (Indirect Direct) |
View |
| 2022-03-11 Sale |
2022-03-15 8:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $6.4757 | $2,176,801 | 24,683,337 (Indirect Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 8:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $7.2965 | $2,188,950 | 10,732,519 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 7:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $10.22 | $1,021,540 | 11,032,519 (Indirect Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 8:09 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $11.73 | $232,964 | 10,500,183 (Indirect Direct) |
View |
| 2022-01-13 Sale |
2022-01-14 8:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $13.76 | $4,692,177 | 26,671,725 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
8,674 | $11.4 | 10,297,052 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,924 | $0 | 10,297,052 (Direct) |
View |
| 2023-08-02 Exercise |
2023-08-04 5:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,297,052 (Direct) |
View |
| 2023-07-20 Conversion |
2023-07-21 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,362,067 (Direct) |
View |
| 2023-07-20 Gift |
2023-07-21 5:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,362,067 (Direct) |
View |
| 2023-07-12 Conversion |
2023-07-14 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,372,067 (Indirect) |
View |
| 2023-07-12 Exercise |
2023-07-14 6:52 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,372,067 (Direct) |
View |
| 2023-07-12 Exercise |
2023-07-14 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,372,067 (Direct) |
View |
| 2023-06-15 Conversion |
2023-06-16 5:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,428,885 (Direct) |
View |
| 2023-06-15 Gift |
2023-06-16 5:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,428,885 (Direct) |
View |
| 2023-06-07 Exercise |
2023-06-09 5:12 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,438,885 (Direct) |
View |
| 2023-06-07 Exercise |
2023-06-09 5:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,438,885 (Direct) |
View |
| 2023-05-15 Tax Withholding |
2023-05-17 6:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,661 | $5.6 | 941,564 (Direct) |
View |
| 2023-01-05 Conversion |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,338 | $0 | 30,174,484 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 6:44 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 30,174,484 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 30,174,484 (Direct) |
View |
| 2023-01-05 Gift |
2023-05-05 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,000 | $0 | 30,174,484 (Direct) |
View |
| 2022-04-25 Conversion(A) |
2023-04-28 4:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
75,500 | $0 | 73,549,979 (Direct) |
View |
| 2022-04-25 Gift(A) |
2023-04-28 4:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
57,000 | $0 | 73,549,979 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 5:30 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,584,055 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 5:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,584,055 (Direct) |
View |
| 2023-04-05 Gift |
2023-04-07 5:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,584,055 (Direct) |
View |
| 2023-03-13 Conversion |
2023-03-15 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,000 | $0 | 10,647,382 (Direct) |
View |
| 2023-03-13 Gift |
2023-03-15 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,000 | $0 | 10,647,382 (Direct) |
View |
| 2023-03-08 Conversion |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,650,382 (Indirect) |
View |
| 2023-03-08 Exercise |
2023-03-10 5:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
93,750 | $0 | 10,650,382 (Direct) |
View |
| 2023-03-08 Exercise |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
93,750 | $2.48 | 10,650,382 (Direct) |
View |
| 2023-03-08 Gift |
2023-03-10 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,650,382 (Direct) |
View |
| 2023-03-02 Conversion |
2023-03-06 6:07 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,771,272 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,346 | $8.44 | 940,927 (Direct) |
View |
| 2023-02-02 Conversion |
2023-02-03 5:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,793,618 (Direct) |
View |
| 2023-02-01 Tax Withholding |
2023-02-03 5:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,382 | $8.55 | 10,793,618 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:11 pm |
N/A 2033-02-01 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,231,450 | $0 | 10,793,618 (Direct) |
View |
| 2023-01-05 Conversion |
2023-01-06 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,584,550 (Direct) |
View |
| 2022-04-25 Gift |
2023-01-06 6:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
57,000 | $0 | 9,584,550 (Direct) |
View |
| 2022-12-01 Conversion |
2022-12-02 6:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,662,550 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:17 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,662,550 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:17 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,662,550 (Direct) |
View |
| 2022-11-15 Tax Withholding |
2022-11-17 6:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,751 | $11.86 | 570,265 (Direct) |
View |
| 2022-11-03 Conversion |
2022-11-04 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,708,011 (Direct) |
View |
| 2022-11-03 Exercise |
2022-11-04 6:39 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,708,011 (Direct) |
View |
| 2022-11-03 Exercise |
2022-11-04 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,708,011 (Direct) |
View |
| 2022-10-06 Conversion |
2022-10-07 7:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,747,204 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 7:19 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,747,204 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 7:19 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,747,204 (Direct) |
View |
| 2022-09-01 Conversion |
2022-09-02 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,785,757 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-02 7:24 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,785,757 (Direct) |
View |
| 2022-09-01 Exercise |
2022-09-02 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,785,757 (Direct) |
View |
| 2022-08-15 Tax Withholding |
2022-08-17 6:32 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,751 | $12.96 | 536,078 (Direct) |
View |
| 2022-08-04 Conversion |
2022-08-05 7:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,843,210 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 7:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,843,210 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-05 7:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,843,210 (Direct) |
View |
| 2022-07-07 Conversion |
2022-07-08 6:36 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,882,535 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-08 6:36 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,882,535 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-08 6:36 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,882,535 (Direct) |
View |
| 2022-06-02 Conversion |
2022-06-06 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 9,909,513 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 8:54 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,909,513 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,909,513 (Direct) |
View |
| 2022-05-16 Tax Withholding |
2022-05-18 7:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,764 | $5.67 | 506,208 (Direct) |
View |
| 2022-05-04 Conversion |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 18,002,176 (Direct) |
View |
| 2022-05-04 Exercise |
2022-05-06 8:13 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 18,002,176 (Direct) |
View |
| 2022-04-28 Conversion |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
42,000 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 19,174,770 (Direct) |
View |
| 2022-04-28 Exercise |
2022-05-02 9:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,024 | $2.48 | 19,174,770 (Direct) |
View |
| 2022-04-21 Conversion |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
54,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-21 Exercise |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
88,020 | $2.48 | 26,290,299 (Direct) |
View |
| 2022-04-25 Gift |
2022-04-25 9:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
12,000 | $0 | 26,290,299 (Direct) |
View |
| 2022-04-18 Conversion |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,185,580 (Direct) |
View |
| 2022-04-18 Exercise |
2022-04-20 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,185,580 (Direct) |
View |
| 2022-04-14 Conversion |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,223,916 (Direct) |
View |
| 2022-04-14 Exercise |
2022-04-18 9:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,223,916 (Direct) |
View |
| 2022-04-08 Conversion |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,260,933 (Direct) |
View |
| 2022-04-08 Exercise |
2022-04-12 8:05 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,260,933 (Direct) |
View |
| 2022-04-07 Conversion |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,300,353 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 8:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,300,353 (Direct) |
View |
| 2022-04-06 Conversion |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,321,071 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 7:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,321,071 (Direct) |
View |
| 2022-04-05 Conversion |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,000 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $0 | 10,359,397 (Direct) |
View |
| 2022-04-05 Exercise |
2022-04-07 9:15 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
44,010 | $2.48 | 10,359,397 (Direct) |
View |
| 2022-03-11 Conversion |
2022-03-15 8:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
336,150 | $0 | 24,683,337 (Direct) |
View |
| 2022-03-07 Conversion |
2022-03-09 8:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
300,000 | $0 | 10,732,519 (Direct) |
View |
| 2022-02-22 Conversion |
2022-02-24 7:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 11,032,519 (Direct) |
View |
| 2022-02-04 Tax Withholding |
2022-02-08 9:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
343 | $11.4 | 11,132,519 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 9:03 pm |
N/A 2032-02-04 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
632,679 | $0 | 11,132,519 (Direct) |
View |
| 2022-01-31 Conversion |
2022-02-02 8:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
19,858 | $0 | 10,500,183 (Direct) |
View |
| 2022-01-13 Conversion |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
341,000 | $0 | 26,671,725 (Direct) |
View |
| 2021-12-28 Gift |
2022-01-14 8:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
75,000 | $0 | 26,671,725 (Direct) |
View |